CN102362966A - Unibract fritillary bulb and loquat leaf medicinal composition and preparation method thereof - Google Patents
Unibract fritillary bulb and loquat leaf medicinal composition and preparation method thereof Download PDFInfo
- Publication number
- CN102362966A CN102362966A CN2011103312603A CN201110331260A CN102362966A CN 102362966 A CN102362966 A CN 102362966A CN 2011103312603 A CN2011103312603 A CN 2011103312603A CN 201110331260 A CN201110331260 A CN 201110331260A CN 102362966 A CN102362966 A CN 102362966A
- Authority
- CN
- China
- Prior art keywords
- bulbus fritillariae
- fritillariae cirrhosae
- radix platycodonis
- mixing
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title abstract description 25
- 241000935235 Fritillaria meleagris Species 0.000 title abstract 6
- 241001092070 Eriobotrya Species 0.000 title abstract 4
- 235000009008 Eriobotrya japonica Nutrition 0.000 title abstract 4
- 239000000843 powder Substances 0.000 claims abstract description 131
- 239000003814 drug Substances 0.000 claims abstract description 62
- 238000002156 mixing Methods 0.000 claims abstract description 55
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 40
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 37
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 30
- 238000001035 drying Methods 0.000 claims abstract description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000000706 filtrate Substances 0.000 claims abstract description 16
- 238000000605 extraction Methods 0.000 claims abstract description 9
- 240000003582 Platycodon grandiflorus Species 0.000 claims description 32
- 229940079593 drug Drugs 0.000 claims description 18
- 230000001476 alcoholic effect Effects 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 11
- 239000000470 constituent Substances 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 8
- 230000006837 decompression Effects 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 230000002879 macerating effect Effects 0.000 claims description 7
- 238000004064 recycling Methods 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 11
- 230000008569 process Effects 0.000 abstract description 6
- 238000001914 filtration Methods 0.000 abstract description 3
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 2
- 239000013078 crystal Substances 0.000 abstract 2
- 241000411851 herbal medicine Species 0.000 abstract 2
- 229940041616 menthol Drugs 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 238000005453 pelletization Methods 0.000 abstract 1
- 239000011505 plaster Substances 0.000 abstract 1
- 238000005516 engineering process Methods 0.000 description 41
- 206010011224 Cough Diseases 0.000 description 16
- 239000002994 raw material Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- 238000004090 dissolution Methods 0.000 description 8
- 235000011437 Amygdalus communis Nutrition 0.000 description 7
- 241000220304 Prunus dulcis Species 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 235000020224 almond Nutrition 0.000 description 7
- 239000013641 positive control Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 206010036790 Productive cough Diseases 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 238000002481 ethanol extraction Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 230000000954 anitussive effect Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 210000004681 ovum Anatomy 0.000 description 3
- 238000005325 percolation Methods 0.000 description 3
- 230000003248 secreting effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000003437 trachea Anatomy 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000007941 film coated tablet Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000009495 sugar coating Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 241001644295 Fritillaria przewalskii Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 230000004676 abdominal muscle contraction Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000000534 thyroid cartilage Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a unibract fritillary bulb and loquat leaf medicinal composition and a preparation method thereof. Four Chinese herbal medicines, namely unibract fritillary bulb, platycodon grandiflorum, loquat leaf, and menthol crystal are selected and the preparation method comprises the following steps of: crushing unibract fritillary bulb into fine powder for later use, crushing platycodon grandiflorum powder into fine powder, taking a certain amount of platycodon grandiflorum fine power for later use, mixing residual platycodon grandiflorum powder and loquat leaf, adding water and decocting, filtering for different times, mixing filtrates, standing, taking supernate, concentrating to obtain plaster, adding platycodon grandiflorum fine power, uniformly mixing, drying, grinding, adding unibract fritillary bulb fine powder, mixing uniformly, pelletizing, drying, adding menthol crystal and auxiliary materials, mixing uniformly, and preparing various formulations according to clinical requirements. The medicine is prepared from non-toxic and pure Chinese herbal medicines, the medicine prepared by the process can be absorbed easily, the utilization rate of active ingredients of the medicine is higher, and the medicine is convenient to take and carry, and is low in preparation cost. If 70 percent ethanol is added into one third unibract fritillary bulb fine power for extraction and then the subsequent operation is performed, the prepared medicine has better curative effects.
Description
The application is dividing an application of application number 200810135060.9, and the applying date is 2008.7.29, and denomination of invention is fritillary-loquat medicinal composition and preparation method thereof.
Technical field
The present invention relates to a kind of Chinese medicine composition and preparation technology field thereof, a kind of fritillary-loquat medicinal composition and preparation method thereof of more specifically saying so.
Background technology
Disclosed Syrupus Bulbus Fritillariae Cirrhosae et Radix Saurauiae Tristylae of version in 2000 is that tradition is used to treat cold cough and bronchitic medicine commonly used, and its prescription is Bulbus Fritillariae Cirrhosae fluidextract 45ml, Radix Platycodonis 45g, Folium Eriobotryae 300g, Mentholum 0.34g.Its method for making is that Bulbus Fritillariae Cirrhosae 45g gets in Bulbus Fritillariae Cirrhosae fluidextract system, is ground into coarse powder, according to the percolation (appendix I O) under fluid extract and the extractum item, makes solvent with 70% ethanol; Flood after 5 days, slowly percolation is collected the liquid 38ml that just filters, and device is preserved in addition; Continue percolation, treat that soluble component filters out fully, the continuous liquid of filtering is concentrated in right amount, the liquid of filtering at the beginning of adding; Mix, continue to be concentrated into 45ml, filter; With Radix Platycodonis and Folium Eriobotryae decocte with water secondary, 2.5 hours for the first time, 2 hours for the second time, collecting decoction; Filter, filtrating is concentrated into an amount of, and adding sucrose 400g and antiseptic are an amount of, boils to make dissolving; Filter, filtrating is mixed with Bulbus Fritillariae Cirrhosae fluidextract, puts coldly, adds the Mentholum and the alcoholic solution of almond essence in right amount; With adding with stirring, add water to 1000ml, stir, promptly get.
Owing in the above-mentioned method for preparing Bulbus Fritillariae Cirrhosae powder is broken into coarse powder, cause this medicine active component to extract not exclusively, bioavailability is not high; Slow curative effect, and owing to adopt syrup, dosage is wayward; Take inconvenience, so improve in order to overcome above-mentioned drawback one after another in each pharmaceutical factory.
Chinese patent document application number is that the application for a patent for invention of 01100336.7 (publication number CN1362181A) discloses a kind of nano fritillary-loquat preparation medicine and preparation method thereof.Its crude drug is with the female 30-70 part of nano Sichuan fritillary bulb, nanometer Radix Platycodonis 30-70 part, nanometer Folium Eriobotryae 200-400 part, nanometer Mentholum 0.2-0.5 part, adopts following method to process: to select the formula Chinese drug material to concoct and be processed into the prepared slices of Chinese crude drugs; Place extraction pot, solubilizer also imports microwave extracting, makes it do the change in polarity motion with hundred million times/second speed of 20-30, and the temperature of its microwave extracting is 30-60 ℃, and the time is 1-10 hour; Above-mentioned extract is carried out concentrating under reduced pressure, and temperature is 30-60 ℃, and the time is 3-72 hour, collects volatile material in the Chinese medicine simultaneously in addition; Decompressed concentrate and volatile material merging are placed spray drying tower, use the Supersonic fluidics, at 30-60 ℃; Under 0 to 0.05MPa the pressure; Dry with the hypersonic velocity instantaneous jet, wherein supersonic jet speed is 330 meters-990 meter per seconds, promptly processes the nanometer prepared slices of Chinese crude drugs.
Though the bioavailability of this nanotechnology medical material is higher, drawback is a complicated process of preparation, and cost is too high, has increased the burden of consumer, is unfavorable for realizing.
Based on the shortcoming that exists in the prior art, the present invention improves the certain methods in the processing technology, can better reach the curative effect of this medicine, and preparation technology is simple, with low cost.
Summary of the invention
The object of the invention just is to work out a kind of fritillary-loquat compositions, overcomes the deficiency of above-mentioned all kinds, does not contain chemical components and provide a kind of by pure Chinese medicine, does not contain hormone, has no side effect, and treating both the exterior and interior reaches better reducing heat and dispersing lung-QI, the effect of preventing phlegm from forming and stopping coughing.This medicament can be prepared into different dosage form to needs of patients in addition, is convenient to take, and is easy to carry.
Another object of the present invention; Work out the four Chinese medicine material that utilizes in the said composition exactly and be raw material, prepare the fritillary-loquat preparation of compositions method that function admirable meets Pharmacopoeia of the People's Republic of China standard, overcome the shortcoming that cost of manufacture is high in the prior art, bioavailability is low; Improved product quality; Reduce cost, taking convenience better meets the availability of medical demand and raw material.
For realizing above-mentioned purpose, fritillary-loquat medicinal composition of the present invention comprises that the following raw medicaments in portion by weight processing and preparing forms: Bulbus Fritillariae Cirrhosae 50-90 part, Radix Platycodonis 50-90 part, Folium Eriobotryae 330-600 part, Mentholum 0.35-0.7 part.
Preferred version comprises following raw medicaments in portion by weight: Bulbus Fritillariae Cirrhosae 61-80 part, Radix Platycodonis 61-80 part, Folium Eriobotryae 400-530 part, Mentholum 0.45-0.6 part.
The method for preparing of fritillary-loquat medicinal composition (technology one) comprises the steps:
1) it is subsequent use to get crude drug respectively by the weight portion of above-mentioned said each component;
2) it is subsequent use Bulbus Fritillariae Cirrhosae powder to be broken into fine powder, again balloonflower powder is broken into fine powder, and it is subsequent use to get 36.9-66.5 part Radix Platycodonis fine powder, and all the other balloonflower powders are mixed the back decocte with water with Folium Eriobotryae, and gradation filters; Merging filtrate left standstill 10-14 hour, got supernatant concentration to clear paste, in clear paste, added the Radix Platycodonis fine powder; Mixing, drying, porphyrize adds the Bulbus Fritillariae Cirrhosae fine powder again; Mixing is granulated, and drying gets active constituents of medicine;
3) in active constituents of medicine, add Mentholum and pharmaceutically acceptable auxiliaries, mixing makes acceptable dosage form clinically.
The said decocting condition of boiling is: decocte with water 1-3 time, the 6-12 that each amount of water is a Folium Eriobotryae doubly decocted 0.5-1.5 hour at every turn.
Respectively Bulbus Fritillariae Cirrhosae, balloonflower powder were broken into the fine powder of 80 orders-150 mesh sieve, through inventor's test of many times, the many-sided factor of comprehensive drug and preparation technology considers, it is the most appropriate respectively Bulbus Fritillariae Cirrhosae, balloonflower powder to be broken into the fine powder of 100 mesh sieves.The relative density of said clear paste is 1.20-1.25 (60 ℃).
The another kind of method for preparing of fritillary-loquat medicinal composition (technology two) comprises the steps:
1) it is subsequent use to get crude drug Bulbus Fritillariae Cirrhosae 50-90 part, Radix Platycodonis 50-90 part, Folium Eriobotryae 330-600 part, Mentholum 0.35-0.7 part;
2) respectively Bulbus Fritillariae Cirrhosae and balloonflower powder are broken into fine powder, it is subsequent use to get 36.9-66.5 part Radix Platycodonis fine powder, and the Bulbus Fritillariae Cirrhosae fine powder mix homogeneously with all the other Radix Platycodonis fine powders and 1/3 amount added the alcoholic solution warm macerating 30 minutes in Radix Platycodonis Bulbus Fritillariae Cirrhosae mixing fine powders; Heating and refluxing extraction 2-3 time each 2-3 hour, merges alcohol extract, decompression recycling ethanol; Filter, get Radix Platycodonis Bulbus Fritillariae Cirrhosae filtrate for later use, medicinal residues mix the back decocte with water with Folium Eriobotryae, and gradation filters; Merging filtrate left standstill 10-14 hour, got supernatant concentration to clear paste, in clear paste, added 36.9-66.5 part Radix Platycodonis fine powder; Mixing, drying, porphyrize adds Radix Platycodonis Bulbus Fritillariae Cirrhosae filtrating and all the other 2/3 Bulbus Fritillariae Cirrhosae fine powders again; Mixing is processed granule, and drying gets active constituents of medicine;
3) in active constituents of medicine, add Mentholum and pharmaceutically acceptable auxiliaries, mixing makes acceptable dosage form clinically.
The said decocting condition of boiling is: decocte with water 1-3 time, the 6-12 that each amount of water is a Folium Eriobotryae doubly decocted 0.5-1.5 hour at every turn.
Respectively Bulbus Fritillariae Cirrhosae, balloonflower powder were broken into the fine powder of 80 orders-150 mesh sieve, through inventor's test of many times, the many-sided factor of comprehensive drug and preparation technology considers, it is the most appropriate respectively Bulbus Fritillariae Cirrhosae, balloonflower powder to be broken into the fine powder of 100 mesh sieves.
The amount of said adding alcoholic solution is 3-5 a times of Radix Platycodonis Bulbus Fritillariae Cirrhosae mixing fine powders amount; The weight percent concentration of alcoholic solution is 60-80%.
The relative density of said clear paste is 1.20-1.25 (60 ℃).
The preferred version of second kind of method for preparing comprises the steps:
1) it is subsequent use to get crude drug Bulbus Fritillariae Cirrhosae 65g, Radix Platycodonis 65g, Folium Eriobotryae 430g, Mentholum 0.5g;
2) respectively Bulbus Fritillariae Cirrhosae and balloonflower powder were broken into the fine powder of 100 mesh sieves, it is subsequent use to get 48g Radix Platycodonis fine powder, with all the other 17g balloonflower powders and 21.7g Bulbus Fritillariae Cirrhosae fine powder mix homogeneously, in Radix Platycodonis Bulbus Fritillariae Cirrhosae mixing fine powders, adds 155g, weight percent concentration and be 70% alcoholic solution warm macerating 30 minutes, heating and refluxing extraction 2 times; 2.5 hours for the first time, 2 hours for the second time, merge alcohol extract, decompression recycling ethanol; Filter, get Radix Platycodonis Bulbus Fritillariae Cirrhosae filtrate for later use, medicinal residues mix the back decocte with water with Folium Eriobotryae, and gradation filters; Merging filtrate left standstill 12 hours, and getting supernatant concentration to relative density is the clear paste of 1.20-1.25 (60 ℃), in clear paste, added 48g Radix Platycodonis fine powder; Mixing, drying, porphyrize adds Radix Platycodonis Bulbus Fritillariae Cirrhosae filtrating and all the other 43.3g Bulbus Fritillariae Cirrhosae fine powders again; Mixing is processed granule, and drying gets active constituents of medicine;
3) in active constituents of medicine, add Mentholum 0.5g and pharmaceutically acceptable auxiliaries, mixing makes acceptable dosage form clinically.
Fritillary-loquat medicinal composition of the present invention has reducing heat and dispersing lung-QI, the effect of preventing phlegm from forming and stopping coughing.Be used for wind-heat invading the lung, the yellow fiery ungratifying ejection of phlegm of the cough expectorant due to the stagnation of fire in the interior, laryngopharynx swelling and pain, distending pain uncomfortable in chest, symptoms such as cold cough and chronic bronchitis.Usage and dosage is: oral, every day, dose was equivalent to primary crude drug 5.0445g.
Adopt above-mentioned technology one and technology two respectively, according to " one one of Chinese pharmacopoeia version in 2000, the appendix rules of preparations is prepared into required clinically various dosage forms.
The beneficial effect of first kind of method for preparing of the present invention (technology one) is: improved bioavailability of medicament, strengthened drug effect, preparation technology is simple, the convenient manufacturing.
Second kind of method for preparing of the present invention (technology two) is that 01100336.7 application for a patent for invention is compared with first kind of method for preparing than application number, has following tangible advantage:
One, granule and the label different in kind of medicine in the preparation process
Get 1/3 Bulbus Fritillariae Cirrhosae fine powder and add the granule rounding that makes behind 70% ethanol extraction, evenly, good fluidity is easy to tabletting, bright and clean, the good hardness of the label that makes.The result is following:
Table 1 technology one, two makes mobility of particle relatively (n=2)
Table 2 technology one, two makes the label mass ratio
Can find out that from above experimental data after getting 1/3 Bulbus Fritillariae Cirrhosae fine powder and adding 70% ethanol extraction, outward appearance, hardness, the friability of the fritillary-loquat sheet that makes all are significantly improved.
Two, the drug dissolution processed of technology one, technology two is different
After getting 1/3 Bulbus Fritillariae Cirrhosae fine powder and adding 70% ethanol extraction, medicine is more loose, in water, more is prone to dissolve, and the dissolution of effective ingredient improves greatly, thereby improves bioavailability of medicament.
Get 6 fritillary-loquat sheets respectively, every part each 1, at the dissolution of different time mensuration active component oleanolic acid, the result is following:
The fritillary-loquat sheet different time dissolution that table 3 technology one, two is processed is (n=2) relatively
Above data show, after getting 1/3 Bulbus Fritillariae Cirrhosae fine powder and adding 70% ethanol extraction, the dissolution of the fritillary-loquat sheet of processing obviously is superior to technology one, and the dissolution curve is seen accompanying drawing 1.
Three, pharmacy test
In the fritillary-loquat tablet recipe; Main pharmacy index was significantly improved after 1/3 Bulbus Fritillariae Cirrhosae fine powder added 70% ethanol extraction: this research is trial drug with the tablet of processing by technology two and technology one respectively; With application number is the positive contrast of medicine, the negative contrast of 0.9% normal saline that 01100336.7 patent of invention makes, and carries out pharmacy tests such as cough-relieving, expectoration, detumescence.The result is following:
1, cough-relieving test
Get 50 of Kunming mouses, body weight body weight (20 ± 2) g, male and female half and half; By the body weight random packet, be divided into blank group, positive controls, one group of fritillary-loquat blade technolgy, two groups of technologies, the blank group gives equal-volume 0.9% normal saline; Every day 1 time, gastric infusion is 3 days continuously, behind the 3rd day administration 40min; Mice is put into sprayer unit, sprays into ammonia (3: 2) with ultrasound atomizer and excite mouse cough, with mice week the time abdominal muscle contractions, the breast that contracts occur, open one's mouth, (cough have or not all can) be the cough standard; Mouse cough number of times in cough latent period (min) of record mice and the 5min, and calculate the cough-relieving rate.The result sees table 4.
Table 4 fritillary-loquat extractum is to the antitussive action (ammonia spraying method) (
n=12) of mice
Annotate: compare with blank control group
*P＜0.05,
*P＜0.01; Compare with technology one,
△P＜0.05.
The result compares with negative control group, one group of fritillary-loquat blade technolgy and equal significant prolongation two groups of mouse coughs of technology incubation period, and P＜0.05 or P＜0.01, the cough number of times also obviously reduces, and two groups of antitussive actions of fritillary-loquat technology obviously are superior to one group of technology; Technology one is approaching with the antitussive action of the positive control that adopts the high-tech nanotechnology.
2, the experiment of reducing phlegm
Get 60 of SD rats, male and female half and half are divided into 5 groups at random; By the body weight random packet, be divided into blank group, positive controls, one group of fritillary-loquat blade technolgy, two groups of technologies, fasting can't help water 12 hours before each group experiment; Urethane 1g/kg intraperitoneal injection of anesthesia is faced upward the position and is fixed, and cuts off and hears skin in the neck; Isolate trachea, hit exactly between two cartilaginous rings at thyroid cartilage lower edge and prick an aperture with sharp-pointed injection needle, inserting internal diameter then is one of 0.8cm capillary glass tube; Make capillary tube just contact the trachea lower surface, so as to drawing the sputum at trachea rear portion, drawing sputum length with capillary tube serves as to estimate the effect of reducing phlegm of medicine.After the preceding 1 hour normal secretory volume of record administration and administration group gastric infusion according to dosage, the sputum secretory volume of rat was respectively organized in the record administration in 1 hour.The result sees table 5
Table 5 fritillary-loquat extractum is to the influence (glass capillary method) (
n=12) of the expectoration amount of rat
Annotate: compare with blank control group
*P＜0.05,
*P＜0.01; Compare with technology one,
△P＜0.05
The result compares with negative control group, and one group of fritillary-loquat blade technolgy and two groups of mice sputums of technology secretory volume increase to some extent, P＜0.05 or P＜0.01, and fritillary-loquat technology obviously is superior to one group of technology for two groups; Technology one is approaching with the positive control effect of adopting the high-tech nanotechnology.
3, antiinflammatory test (foot swelling of Ovum Gallus domesticus album property)
Get 60 of SD rats, male and female half and half are divided into 5 groups at random, are divided into blank group, positive controls, one group of fritillary-loquat blade technolgy, two groups of technologies, and each organizes gastric infusion according to dosage, every day 1 time, for three days on end.Before the last administration, make a labelling, with the right back sufficient sole of the foot volume of volumetric measurement, as causing right back sufficient normal volume before the inflammation at every the right back sole of the foot of rat place.1h after the last administration at every right back sufficient sole of the foot skin injection Ovum Gallus domesticus album 0.1ml/ of rat only, measures to inject and causes right sufficient volume behind scorching back 1h, 2h, the 3h, and deduct cause scorching before the right back sufficient normal volume of rat, as the paw swelling of each Mus at different time.The result sees table 6.
Table 6 fritillary-loquat extractum is to the bullate influence (glass capillary method) (
n=12) of Ovum Gallus domesticus album property foot
Annotate: compare with blank control group
*P＜0.05,
*P＜0.01; Compare with technology one,
△P＜0.05
The result compares with negative control group, and the mice detumescence effect that fritillary-loquat sheet, one group of technology and technology are two groups is remarkable, P＜0.05 or P＜0.01, and two groups of antitussive actions of fritillary-loquat technology obviously are superior to one group of technology; Technology one is suitable with the detumescence effect of the positive control that adopts the high-tech nanotechnology.
In sum, outward appearance, hardness, the friability of the fritillary-loquat compositions that second method of the present invention is prepared all are significantly improved, and the dissolution of effective ingredient improves greatly, thereby have improved bioavailability of medicament.In addition through pharmacodynamics test, the fritillary-loquat sheet that second method of the present invention is prepared in cough-relieving, reduce phlegm, the effect of aspect such as antiinflammatory is superior to first method of the present invention, slightly is superior to nanotechnology; The compositions that first method is prepared is suitable with the positive control effect that adopts the high-tech nanotechnology.Because the complicated process of preparation of nanotechnology, cost is expensive, be unfavorable for realizing, so, to take all factors into consideration, first method of the present invention and second method are saved cost, are accepted by manufacturer and patient more easily.
Description of drawings
Fig. 1 is the dissolution curve chart of adopting process two of the present invention and technology one.
The specific embodiment
Below with embodiment medicine of the present invention and preparation method thereof is described further, help the present invention is understood, embodiment does not limit protection scope of the present invention, its protection domain is decided by claim.
Embodiment 1
With Bulbus Fritillariae Cirrhosae 65g, Radix Platycodonis 65g, Folium Eriobotryae 430g, Mentholum 0.5g four Chinese medicine material is raw material; The fine powder that Bulbus Fritillariae Cirrhosae 65g was ground into 100 mesh sieves is subsequent use; Radix Platycodonis 65g was ground into the fine powder of 100 mesh sieves, and it is subsequent use to get 48g Radix Platycodonis fine powder, and all the other balloonflower powders are mixed back decocte with water secondary with Folium Eriobotryae 430g; Add for the first time the water of 10 times of amounts of mixture, decocted 1 hour; Add for the second time the water of 8 times of amounts of mixture, decocted 1 hour, gradation filters, and merging filtrate left standstill 12 hours; Getting supernatant concentration to relative density is the clear paste of 1.20-1.25 (60 ℃), in clear paste, adds 48g Radix Platycodonis fine powder, mixing, drying, porphyrize; Add the Bulbus Fritillariae Cirrhosae fine powder, mixing is granulated drying; Add Mentholum 0.5g and almond essence 5ml, mixing, tabletting makes tablet.
Embodiment 2
With Bulbus Fritillariae Cirrhosae 50g, Radix Platycodonis 50g, Folium Eriobotryae 330g, Mentholum 0.35g four Chinese medicine material is raw material; The fine powder that Bulbus Fritillariae Cirrhosae 50g was ground into 120 mesh sieves is subsequent use; Radix Platycodonis 50g was ground into the fine powder of 120 mesh sieves, and it is subsequent use to get 36.9g Radix Platycodonis fine powder, and all the other balloonflower powders are mixed back decocte with water 2 times with Folium Eriobotryae 330g; Add for the first time the water of 8 times of amounts of mixture, decocted 1 hour; Add for the second time the water of 6 times of amounts of mixture, decocted 0.5 hour, gradation filters, and collecting decoction left standstill 10 hours; Getting supernatant concentration to relative density is the clear paste of 1.20-1.25 (60 ℃), in clear paste, adds 36.9g Radix Platycodonis fine powder, mixing, drying; Porphyrize adds the Bulbus Fritillariae Cirrhosae fine powder, and mixing is granulated; Drying adds Mentholum 0.35g and starch 45g, and mixing promptly gets granule.
Embodiment 3
With Bulbus Fritillariae Cirrhosae 90g, Radix Platycodonis 90g, Folium Eriobotryae 600g, Mentholum 0.7g four Chinese medicine material is raw material; The fine powder that Bulbus Fritillariae Cirrhosae 90g was ground into 150 mesh sieves is subsequent use; Radix Platycodonis 90g was ground into the fine powder of 150 mesh sieves; It is subsequent use to get 66.5g Radix Platycodonis fine powder; All the other balloonflower powders are mixed back decocte with water 3 times with Folium Eriobotryae 600g, add the water of 12 times of amounts of all the other balloonflower powders and Folium Eriobotryae mixture for the first time, decocted 1.5 hours; Add for the second time the water of 10 times of amounts of mixture, decocted 1 hour; The water that adds 8 times of amounts of mixture for the third time decocted 0.5 hour, and gradation filters, and collecting decoction left standstill 14 hours; Getting supernatant concentration to relative density is the clear paste of 1.20-1.25 (60 ℃), in clear paste, adds 66.5g Radix Platycodonis fine powder, mixing, drying, porphyrize; Add the Bulbus Fritillariae Cirrhosae fine powder, mixing is granulated, and drying adds Mentholum 0.7g and starch 84g; Mixing is granulated, and is encapsulated, makes capsule.
Embodiment 4
Used employing crude drug of present embodiment and preparation method thereof is basically with embodiment 1, and having only different is to be raw material with Bulbus Fritillariae Cirrhosae 61g, Radix Platycodonis 61g, Folium Eriobotryae 400g, Mentholum 0.45g four Chinese medicine material;
Radix Platycodonis 61g was ground into the fine powder of 150 mesh sieves, and it is subsequent use to get 45g Radix Platycodonis fine powder, and all the other balloonflower powders are mixed back decocte with water 2 times with Folium Eriobotryae 400g;
Add Mentholum 0.45g and almond essence 5.4ml, mixing, tabletting, the bag film-coat makes Film coated tablets.
Embodiment 5
Crude drug and preparation method thereof that present embodiment adopts is basically with embodiment 1, and having only different is to be raw material with Bulbus Fritillariae Cirrhosae 80g, Radix Platycodonis 80g, Folium Eriobotryae 530g, Mentholum 0.6g four Chinese medicine material;
Radix Platycodonis 80g was ground into the fine powder of 80 mesh sieves, and it is subsequent use to get 59g Radix Platycodonis fine powder, and all the other balloonflower powders are mixed back decocte with water 2 times with Folium Eriobotryae 530g;
Add Mentholum 0.6g and almond essence 5ml, mixing, tabletting, sugar coating makes coated tablet.
Embodiment 6
With Bulbus Fritillariae Cirrhosae 65g, Radix Platycodonis 65g, Folium Eriobotryae 430g, Mentholum 0.5g four Chinese medicine material is raw material; Respectively 65g Bulbus Fritillariae Cirrhosae and 65g balloonflower powder were broken into the fine powder of 100 mesh sieves, it is subsequent use to get 48g Radix Platycodonis fine powder, with all the other 17g balloonflower powders and 21.7g Bulbus Fritillariae Cirrhosae fine powder mix homogeneously; In Radix Platycodonis Bulbus Fritillariae Cirrhosae mixing fine powders, added 155g, weight percent concentration and be 70% alcoholic solution warm macerating 30 minutes, heating and refluxing extraction 2 times, 2.5 hours for the first time; 2 hours for the second time, merge alcohol extract, decompression recycling ethanol; Filter, get Radix Platycodonis Bulbus Fritillariae Cirrhosae filtrate for later use, medicinal residues mix back decocte with water secondary with Folium Eriobotryae 430g; Add for the first time the water of 10 times of amounts of all the other balloonflower powders and Folium Eriobotryae mixture, decocted 1 hour; Add for the second time the water of 8 times of amounts of mixture, decocted 1 hour, gradation filters, and merging filtrate left standstill 12 hours; Getting supernatant concentration to relative density is the clear paste of 1.20-1.25 (60 ℃), in clear paste, adds 48g Radix Platycodonis fine powder, mixing, drying, porphyrize; Add Radix Platycodonis Bulbus Fritillariae Cirrhosae filtrating and all the other 43.3g Bulbus Fritillariae Cirrhosae fine powders, mixing is granulated drying; Add Mentholum 0.5g and almond essence 5ml again, mixing, tabletting makes tablet.
Embodiment 7
With Bulbus Fritillariae Cirrhosae 50g, Radix Platycodonis 50g, Folium Eriobotryae 330g, Mentholum 0.35g four Chinese medicine material is raw material; Respectively 50g Bulbus Fritillariae Cirrhosae and 50g balloonflower powder were broken into the fine powder of 120 mesh sieves, it is subsequent use to get 36.9g Radix Platycodonis fine powder, with all the other 13.1g balloonflower powders and 16.7g Bulbus Fritillariae Cirrhosae fine powder mix homogeneously; In Radix Platycodonis Bulbus Fritillariae Cirrhosae mixing fine powders, added 89g, weight percent concentration and be 60% alcoholic solution warm macerating 30 minutes, heating and refluxing extraction 2 times, 3 hours for the first time; 2 hours for the second time, merge alcohol extract, decompression recycling ethanol; Filter, get Radix Platycodonis Bulbus Fritillariae Cirrhosae filtrate for later use, medicinal residues mix back decocte with water secondary with Folium Eriobotryae 330g; Add for the first time the water of 10 times of amounts of all the other balloonflower powders and Folium Eriobotryae mixture, decocted 1 hour; Add for the second time the water of 8 times of amounts of mixture, decocted 1 hour, gradation filters, and merging filtrate left standstill 10 hours; Getting supernatant concentration to relative density is the clear paste of 1.20-1.25 (60 ℃), in clear paste, adds 36.9g Radix Platycodonis fine powder, mixing, drying, porphyrize; Add Bulbus Fritillariae Cirrhosae filtrating and all the other 33.3 Bulbus Fritillariae Cirrhosae fine powders, mixing is granulated drying; Add Mentholum 0.35g and starch 40g, mixing is granulated, and makes granule.
Embodiment 8
With Bulbus Fritillariae Cirrhosae 90g, Radix Platycodonis 90g, Folium Eriobotryae 600g, Mentholum 0.7g four Chinese medicine material is raw material; Respectively 90g Bulbus Fritillariae Cirrhosae and 90g balloonflower powder were broken into the fine powder of 80 mesh sieves, it is subsequent use to get 66.5g Radix Platycodonis fine powder, with all the other 23.5g balloonflower powders and 30g Bulbus Fritillariae Cirrhosae fine powder mix homogeneously; In Radix Platycodonis Bulbus Fritillariae Cirrhosae mixing fine powders, added 268g, weight percent concentration and be 80% alcoholic solution warm macerating 30 minutes, heating and refluxing extraction 3 times, 3 hours for the first time; 2.5 hours for the second time, 2 hours for the third time, merge alcohol extract; Decompression recycling ethanol filters, and gets Radix Platycodonis Bulbus Fritillariae Cirrhosae filtrate for later use; Medicinal residues mix back decocte with water 3 times with Folium Eriobotryae 600g, add the water of 12 times of amounts of all the other balloonflower powders and Folium Eriobotryae mixture for the first time, decoct 1.5 hours; Add for the second time the water of 10 times of amounts of mixture, decocted 1 hour; The water that adds 8 times of amounts of mixture for the third time decocted 0.5 hour, and gradation filters, and collecting decoction left standstill 14 hours; Getting supernatant concentration to relative density is the clear paste of 1.20-1.25 (60 ℃), in clear paste, adds 66.5g Radix Platycodonis fine powder, mixing, drying, porphyrize; Add Bulbus Fritillariae Cirrhosae filtrating and all the other 60g Bulbus Fritillariae Cirrhosae fine powders, mixing is granulated, and drying adds Mentholum 0.7g and starch 84g; Mixing is granulated, and is encapsulated, makes capsule.
Embodiment 9
Crude drug and preparation method thereof that present embodiment adopts is basically with embodiment 6, and having only different is to be raw material with Bulbus Fritillariae Cirrhosae 61g, Radix Platycodonis 61g, Folium Eriobotryae 400g, Mentholum 0.45g four Chinese medicine material;
Respectively 61g Bulbus Fritillariae Cirrhosae and 61g balloonflower powder were broken into the fine powder of 120 mesh sieves, it is subsequent use to get 45g Radix Platycodonis fine powder, with all the other 16g balloonflower powders and 20.3g Bulbus Fritillariae Cirrhosae fine powder mix homogeneously, in Radix Platycodonis Bulbus Fritillariae Cirrhosae mixing fine powders, adds the 145g alcoholic solution;
Add Bulbus Fritillariae Cirrhosae filtrating and all the other 40.7g Bulbus Fritillariae Cirrhosae fine powders, mixing is granulated, and drying adds Mentholum 0.45g and almond essence 5.4ml, mixing, and tabletting, the bag film-coat makes Film coated tablets.
Crude drug and preparation method thereof that present embodiment adopts is basically with embodiment 6, and having only different is to be raw material with Bulbus Fritillariae Cirrhosae 80g, Radix Platycodonis 80g, Folium Eriobotryae 530g, Mentholum 0.6g four Chinese medicine material;
Respectively 80g Bulbus Fritillariae Cirrhosae and 80g balloonflower powder were broken into the fine powder of 150 mesh sieves, it is subsequent use to get 59g Radix Platycodonis fine powder, with all the other 21g balloonflower powders and 26.7g Bulbus Fritillariae Cirrhosae fine powder mix homogeneously, in Radix Platycodonis Bulbus Fritillariae Cirrhosae mixing fine powders, adds the 143g alcoholic solution;
Add Bulbus Fritillariae Cirrhosae filtrating and all the other 53.3g Bulbus Fritillariae Cirrhosae fine powders, mixing is granulated, and drying adds Mentholum 0.6g and sucrose 100g, adds water to 1000ml, and packing makes syrup.
Embodiment 11
Crude drug and preparation method thereof that present embodiment adopts is basically with embodiment 6, has only different to be, adds Mentholum 0.5g and almond essence 4ml, mixing, and tabletting, sugar coating makes coated tablet.
Claims (7)
1. fritillary-loquat medicinal composition is characterized in that:
1) it is subsequent use to get crude drug Bulbus Fritillariae Cirrhosae 50-90 part, Radix Platycodonis 50-90 part, Folium Eriobotryae 330-600 part, Mentholum 0.35-0.7 part;
2) respectively Bulbus Fritillariae Cirrhosae and balloonflower powder are broken into fine powder, it is subsequent use to get 36.9-66.5 part Radix Platycodonis fine powder, and the Bulbus Fritillariae Cirrhosae fine powder mix homogeneously with all the other Radix Platycodonis fine powders and 1/3 amount added the alcoholic solution warm macerating 30 minutes in Radix Platycodonis Bulbus Fritillariae Cirrhosae mixing fine powders; Heating and refluxing extraction 2-3 time each 2-3 hour, merges alcohol extract, decompression recycling ethanol; Filter, get Radix Platycodonis Bulbus Fritillariae Cirrhosae filtrate for later use, medicinal residues mix the back decocte with water with Folium Eriobotryae, and gradation filters; Merging filtrate left standstill 10-14 hour, got supernatant concentration to clear paste, in clear paste, added 36.9-66.5 part Radix Platycodonis fine powder; Mixing, drying, porphyrize adds Radix Platycodonis Bulbus Fritillariae Cirrhosae filtrating and all the other 2/3 Bulbus Fritillariae Cirrhosae fine powders again; Mixing is processed granule, and drying gets active constituents of medicine;
3) in active constituents of medicine, add Mentholum and pharmaceutically acceptable auxiliaries, mixing makes acceptable dosage form clinically.
2. the method for preparing of fritillary-loquat medicinal composition according to claim 1, it is characterized in that: the condition of said decocte with water is: decocte with water 1-3 time, the 6-12 that each amount of water is a Folium Eriobotryae doubly decocted 0.5-1.5 hour at every turn.
3. the method for preparing of fritillary-loquat medicinal composition according to claim 1 is characterized in that: the fine powder that respectively Bulbus Fritillariae Cirrhosae, balloonflower powder was broken into 80 orders-150 mesh sieve.
4. the method for preparing of fritillary-loquat medicinal composition according to claim 1 is characterized in that: the amount of said adding alcoholic solution be Radix Platycodonis Bulbus Fritillariae Cirrhosae mixing fine powders amount 3-5 doubly.
5. the method for preparing of fritillary-loquat medicinal composition according to claim 1, it is characterized in that: the weight percent concentration of said alcoholic solution is 60-80%.
6. the method for preparing of fritillary-loquat medicinal composition according to claim 1, it is characterized in that: the relative density of said clear paste is 1.20-1.25 (60 ℃).
7. fritillary-loquat medicinal composition is characterized in that:
1) it is subsequent use to get crude drug Bulbus Fritillariae Cirrhosae 65g, Radix Platycodonis 65g, Folium Eriobotryae 430g, Mentholum 0.5g;
2) respectively Bulbus Fritillariae Cirrhosae and balloonflower powder were broken into the fine powder of 100 mesh sieves, it is subsequent use to get 48g Radix Platycodonis fine powder, with all the other 17g balloonflower powders and 21.7g Bulbus Fritillariae Cirrhosae fine powder mix homogeneously, in Radix Platycodonis Bulbus Fritillariae Cirrhosae mixing fine powders, adds 155g, weight percent concentration and be 70% alcoholic solution warm macerating 30 minutes, heating and refluxing extraction 2 times; 2.5 hours for the first time, 2 hours for the second time, merge alcohol extract, decompression recycling ethanol; Filter, get Radix Platycodonis Bulbus Fritillariae Cirrhosae filtrate for later use, medicinal residues mix the back decocte with water with Folium Eriobotryae, and gradation filters; Merging filtrate left standstill 12 hours, and getting supernatant concentration to relative density is the clear paste of 1.20-1.25 (60 ℃), in clear paste, added 48g Radix Platycodonis fine powder; Mixing, drying, porphyrize adds Radix Platycodonis Bulbus Fritillariae Cirrhosae filtrating and all the other 43.3g Bulbus Fritillariae Cirrhosae fine powders again; Mixing is processed granule, and drying gets active constituents of medicine;
3) in active constituents of medicine, add Mentholum 0.5g and pharmaceutically acceptable auxiliaries, mixing makes acceptable dosage form clinically.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103312603A CN102362966A (en) | 2008-07-29 | 2008-07-29 | Unibract fritillary bulb and loquat leaf medicinal composition and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103312603A CN102362966A (en) | 2008-07-29 | 2008-07-29 | Unibract fritillary bulb and loquat leaf medicinal composition and preparation method thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200810135060A Division CN101637561A (en) | 2008-07-29 | 2008-07-29 | Fritillary-loquat medicinal composition and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102362966A true CN102362966A (en) | 2012-02-29 |
Family
ID=45689582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103312603A Pending CN102362966A (en) | 2008-07-29 | 2008-07-29 | Unibract fritillary bulb and loquat leaf medicinal composition and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102362966A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362855A (en) * | 2015-02-04 | 2016-03-02 | 徐应乐 | Plaster for treating wind heat cough of children |
| CN105687954A (en) * | 2015-01-15 | 2016-06-22 | 徐应乐 | Traditional Chinese medicine for treating wind-heat type cough |
| CN105878700A (en) * | 2016-04-29 | 2016-08-24 | 江西南昌济生制药厂 | Bulbus Fritillariae Cirrhosae and loquat capsules and preparation method and application thereof |
| CN107469041A (en) * | 2017-08-31 | 2017-12-15 | 黄籍平 | A kind of medicine for treating acute or chronic infantile bronchitis |
| CN108992580A (en) * | 2018-09-25 | 2018-12-14 | 广西中医药大学附属瑞康医院 | Chinese medicine composition and preparation method thereof for preventing phlegm from forming and stopping coughing |
| CN110090262A (en) * | 2018-01-30 | 2019-08-06 | 北京盈科瑞创新药物研究有限公司 | A kind of Compound Loquat cough-relieving sucking pharmaceutical solutions and preparation method thereof |
| CN116172938A (en) * | 2023-03-15 | 2023-05-30 | 北京工商大学 | A kind of preparation technology of Chuanbei loquat composition with soothing effect |
-
2008
- 2008-07-29 CN CN2011103312603A patent/CN102362966A/en active Pending
Non-Patent Citations (2)
| Title |
|---|
| 万国庆: "贝母枇杷糖浆的剂型改进", 《浙江药学》 * |
| 国家中医药管理局《中华本草》编委会: "《中华本草》", 30 September 1999, 上海科学技术出版社 * |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105687954A (en) * | 2015-01-15 | 2016-06-22 | 徐应乐 | Traditional Chinese medicine for treating wind-heat type cough |
| CN105362855A (en) * | 2015-02-04 | 2016-03-02 | 徐应乐 | Plaster for treating wind heat cough of children |
| CN105878700A (en) * | 2016-04-29 | 2016-08-24 | 江西南昌济生制药厂 | Bulbus Fritillariae Cirrhosae and loquat capsules and preparation method and application thereof |
| CN107469041A (en) * | 2017-08-31 | 2017-12-15 | 黄籍平 | A kind of medicine for treating acute or chronic infantile bronchitis |
| CN110090262A (en) * | 2018-01-30 | 2019-08-06 | 北京盈科瑞创新药物研究有限公司 | A kind of Compound Loquat cough-relieving sucking pharmaceutical solutions and preparation method thereof |
| CN108992580A (en) * | 2018-09-25 | 2018-12-14 | 广西中医药大学附属瑞康医院 | Chinese medicine composition and preparation method thereof for preventing phlegm from forming and stopping coughing |
| CN108992580B (en) * | 2018-09-25 | 2021-08-20 | 广西中医药大学附属瑞康医院 | Traditional Chinese medicine composition for eliminating phlegm and relieving cough and preparation method thereof |
| CN116172938A (en) * | 2023-03-15 | 2023-05-30 | 北京工商大学 | A kind of preparation technology of Chuanbei loquat composition with soothing effect |
| CN116172938B (en) * | 2023-03-15 | 2024-05-03 | 北京工商大学 | Preparation process of Chuanbei loquat composition with soothing effect |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101637561A (en) | Fritillary-loquat medicinal composition and preparation method thereof | |
| CN102362966A (en) | Unibract fritillary bulb and loquat leaf medicinal composition and preparation method thereof | |
| CN101366844B (en) | New use of loquat flower and its extract | |
| CN111358839B (en) | Formula granules of polygonum capitatum and preparation method thereof | |
| CN102813801A (en) | Traditional Tibetan medicine for treating cough and preparation method thereof | |
| CN102319357B (en) | Lipid-lowering dispersible tablets and preparation technology thereof | |
| CN101278958A (en) | Feining dropping pill and method of preparing the same | |
| CN111358906B (en) | Traditional Chinese medicine composition suitable for exogenous diseases | |
| CN102764294B (en) | Cough relieving and sputum eliminating combination and preparation method thereof | |
| CN101732389A (en) | Chinese medicinal composition for treating traumatic injury and promoting fracture healing and preparation method thereof | |
| CN102784244B (en) | Externally applied traditional Chinese medicine for treating breast lumps | |
| CN102895620A (en) | Preparation technology and production method for integrated new formulation of licorice heart-draining decoction | |
| CN102204963B (en) | Composite armadillidium vulgare extract and preparation method and application thereof to pain relieving medicaments | |
| CN101147767B (en) | Preparation method of medicinal composition for treating acne | |
| CN107854671A (en) | A Na series anaesthetic intragastric floating sustained-release preparations and preparation method thereof | |
| CN101219200B (en) | Traditional Chinese medicine soft capsule and preparing method thereof | |
| CN110859914B (en) | Traditional Chinese medicine film for treating oral ulcer | |
| CN104055963B (en) | A kind of fat reducing Chinese medicine composition and preparation method | |
| CN102106999A (en) | Chinese medicinal compound preparation for treating dysphagia due to stroke and preparation method thereof | |
| CN1562143A (en) | Method for preparing Chinese medicine sticking sheet for treating recurrent ulcer of mouth and dermatitis stomatitis | |
| CN100408058C (en) | Stomach-power Chinese medicine preparation and preparing method | |
| CN102058830B (en) | Medicinal composition preparation and preparation method thereof | |
| CN1709326A (en) | Method for preparing concentrated pill for treating mammary gland proliferation disease | |
| CN102579801B (en) | Traditional Chinese medicine preparation for treating diabetic syndrome and preparation method of same | |
| CN102847094A (en) | Preparation process of integration-type novel formulation of Cinnamomum cassia and Paeonia lactiflora decoction and production method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120229 |